Back to Search Start Over

Fibroblast heterogeneity in prostate carcinogenesis.

Authors :
ChallaSivaKanaka S
Vickman RE
Kakarla M
Hayward SW
Franco OE
Source :
Cancer letters [Cancer Lett] 2022 Jan 28; Vol. 525, pp. 76-83. Date of Electronic Publication: 2021 Oct 29.
Publication Year :
2022

Abstract

Our understanding of stromal components, specifically cancer-associated fibroblasts (CAF), in prostate cancer (PCa), has evolved from considering these cells as inert bystanders to acknowledging their significance as players in prostate tumorigenesis. CAF are multifaceted-they promote cancer cell growth, migration and remodel the tumor microenvironment. Although targeting CAF could be a promising strategy for PCa treatment, they incorporate a high but undefined degree of intrinsic cellular heterogeneity. The interaction between CAF subpopulations, with the normal and tumor epithelium and with other cell types is not yet characterized. Defining these interactions and the critical signaling nodes that support tumorigenesis will enable the development of novel strategies to control prostate cancer progression. Here we will discuss the origins, molecular and functional heterogeneity of CAF in PCa. We highlight the challenges associated with delineating CAF heterogeneity and discuss potential areas of research that would assist in expanding our knowledge of CAF and their role in PCa tumorigenesis.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-7980
Volume :
525
Database :
MEDLINE
Journal :
Cancer letters
Publication Type :
Academic Journal
Accession number :
34715252
Full Text :
https://doi.org/10.1016/j.canlet.2021.10.028